Span Divergent Ltd

524727·BSE·
₹23.15▲ +1.10 (+4.99%)
Market Cap16.81 Cr
PE Ratio-5.90
Volume200
Day High - Low23.15 - 23.15
52W High-Low51.49 - 20.52

Span Divergent Ltd (524727): company summary

The company's revenue grew 92.3% annually, but net profit remained a loss, widening from ₹1 crore to ₹3 crore.

Span Divergent Ltd (524727) is a micro-cap Healthcare company valued at ₹17 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move
Span Divergent Ltd last traded at ₹23.15, up 4.99% on the day.
Recent developments
2026-06-30: The company reported a net loss of ₹1 crore in the latest quarter, following a loss of ₹1 crore in the previous quarter. 2026-03-31: The company's revenue was ₹5 crore, with a net loss of ₹1 crore, compared to ₹4 crore revenue and a ₹1 crore loss in the prior quarter.
Financial performance
The company's revenue grew 92.3% annually, but net profit remained a loss, widening from ₹1 crore to ₹3 crore. The latest quarter saw revenue fall 4.7% year-on-year while the net loss widened from ₹0 crore to ₹1 crore.
Valuation multiples
A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at 1.43 times book value.
Things to watch
The company's net profit margin worsened to -17.1% from -14.3% in the prior year. The net loss widened from ₹1 crore to ₹3 crore annually. The promoter holding decreased by 15.9% over the last three years.
Where it stands
The company's business shows strong revenue growth, but net profit remains a loss, with the latest quarter's loss widening. The promoter holding has decreased over the last three years, and the stock is 43.1% below its 52-week high.

Summarised by DocStoX's model on 2026-09-10 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score
3.2/10
Poor
Fair Value
Sign in to see
ROE
-16.83%
Weak
P/E
-5.90x
Loss-making
Debt / Equity
0.48
Moderate
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

52W₹20.52
₹51.49
DocStoX take

Supported by growth (7.5) and valuation (6.0), but held back by momentum (0.0). Growth looks strong at 7.5, but that is offset by momentum at 0.0 and quality at 0.7. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
3.2
/10
Poor
Quality
Weak
ROE -16.8%
Valuation
Fair
P/B 1.4× on assets (no earnings to value)
Growth
Strong
Revenue +18.4% 5Y CAGR
Risk
Moderate
D/E 0.48
Momentum
Weak
8% of 52-week range

At a glance

Market Cap
₹17 Cr
52W High / Low
₹51 / ₹21
Dividend Yield
0.00%
Promoter Holding
48.13%
EPS (TTM)
₹-3.44
Book Value
₹20.46

Key highlights

  • Revenue compounding 18% a year
  • Loss-making — no meaningful P/E
  • Loss-making in some of the last 5 years
1 Positive4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Span Divergent Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.